INTRODUCTION
============

Efficient delivery of proteins to their final location is fundamental for neurons. This is in particular important for proteins operating at the tip of processes, which can be far from the cell soma. Mechanisms of polarized membrane trafficking to establish the composition of the growth cone membrane have been described ([@B26]). However, the molecular determinants that generate and maintain the distribution of cytosolic proteins in neurons are less well understood.

Posttranslational modifications such as phosphorylation and lipidation may tag cytosolic proteins for transport and regulate their distribution between soma and processes. Phosphorylation adds negative charge and can switch the protein conformation to affect protein--protein or protein--lipid interactions. Lipidation increases the hydrophobicity of proteins, and the lipid anchor may attach the intrinsically soluble protein to a membrane ([@B35]). S-palmitoylation is the most frequently observed lipid modification of neuronal proteins. It is unique in that this lipidation is reversible ([@B15]). Thus dynamic and reversible phosphorylation and S-palmitoylation may determine the rate and direction of protein shuttling between intracellular compartments according to physiological needs.

Essentially all protein palmitoylation depends on DHHC proteins, which are polytopic membrane proteins. As a result, palmitoylation of proteins is restricted to the cytoplasmic surface of intracellular membrane compartments ([@B8]), mainly at the Golgi as a super-reaction center for palmitoylation ([@B45]). Active DHHC proteins have also been detected at post-Golgi membranes, including the plasma membrane of neuronal dendrites ([@B39]) and recycling endosomes and the plasma membrane in PC12 cells ([@B19]). In contrast, phosphorylation can occur in all intracellular compartments. Thus the question arises whether and how palmitoylation and phosphorylation interplay in regulating the sorting of cytosolic proteins in neurons.

Here the neuronal growth-associated protein GAP43 (also known as F1, B-50, GAP-48, 48K4.5, P-57, pp46, and neuromodulin) serves as a model protein to analyze the role of phosphorylation and lipidation in protein sorting between the soma and the growth cone of a nerve cell. GAP43 is a phosphorylated and S-palmitoylated protein and is enriched in the tips of extending neurites during nerve cell growth and regeneration ([@B49]). GAP43 is subject to phosphorylation by several kinases, including protein kinase C (PKC), casein kinase II, and proline-directed kinases ([@B2], [@B3]; [@B51]). With respect to a regulatory role, phosphorylation of GAP43 by PKC at a unique site (Ser-41) appears to be most relevant. In vivo, PKC phosphorylation of GAP43 is enhanced in the distal axon and growth cone via the βII PKC isoform, where it can be stimulated by extracellular factors, thereby coupling GAP43 phosphorylation to neuronal guidance cues ([@B37]). Phosphorylated GAP43 appears to represent the functionally active form, since it is found in growth cones that establish stable contacts with other cells, whereas unphosphorylated GAP43 is present in retracting growth cones ([@B13]). In agreement, transgenic mice overexpressing pseudophosphorylated GAP43 show enhanced sprouting, whereas animals with nonphosphorylatable GAP43 exhibit less sprouting ([@B1]). Because the activation state of GAP43 appears to correlate with its localization, phosphorylation may directly or indirectly influence the intracellular distribution of GAP43. Indeed, phosphorylation at Ser-41 affects the association of GAP43 with the membrane skeleton ([@B38]); however, the relevance of this interaction for regulating GAP43 trafficking remains to be shown.

The first 10 amino acids, which are encoded by exon 1, are important for membrane binding of GAP43. Within this region, Cys-3 and Cys-4 are crucial and undergo reversible, covalent addition of palmitic acid ([@B49]). Mutation of Cys-3 and Cys-4 prevents membrane binding ([@B64]). GAP43 is initially synthesized as a soluble protein on free ribosomes in the cell body and becomes palmitoylated and attached to membranes posttranslationally ([@B49]). About 30% of GAP43 was found to travel at fast axonal transport rate in regenerating sciatic nerves in vivo ([@B52]), whereas GAP43 was found mostly to be localized at the cytosolic face of the plasma membrane in the adult pyramidal tract ([@B18]). Ultrastructural analysis revealed that a minor portion of GAP43 is also associated with vesicles ([@B57]), where it colocalizes with the synaptic vesicle marker synaptophysin ([@B56]). This poses the question how GAP43 gets sorted to the distal process under conditions in which only a minority is localized to vesicles.

To scrutinize the interplay of phosphorylation and lipidation in sorting of GAP43 to neuronal growth cones, we prepared a panel of photoactivatable green fluorescent protein (PAGFP)--tagged GAP43 constructs. We analyzed their distribution between plasma membrane and cytosol by microsphere separation, followed their mobility by time-lapse fluorometry, and determined retention and diffusion constants by spatially restricted photoactivation experiments. Using total internal reflection fluorescence (TIRF) microscopy, we determined association and transport of GAP43 with exocytic vesicles. Simulations were performed to determine the relative contribution of diffusion, membrane reaction, and transport for sorting to growth cones.

RESULTS
=======

Expression of PAGFP-tagged GAP43 constructs in neuronally differentiated cells
------------------------------------------------------------------------------

To generate a neuronal model to allow us to determine the dynamics and distribution of wild-type and modified GAP43 in living cells, we prepared a panel of constructs in which PAGFP was fused to GAP43~wt~ and phosphoblocking (GAP43~S41A~) and phosphomimicking GAP43 mutants (GAP43~S41D~) at Ser-41 ([Figure 1A](#F1){ref-type="fig"}). According to Simple Modular Architecture Research Tool (SMART) analysis ([@B47]; [@B29]), Ser-41 is located in an IQ domain, which serves as a binding site for EF-hand proteins such as calmodulin ([@B44]). For comparison, we used a cytosolic reference protein (3×PAGFP) and a PAGFP construct with a farnesylation signal from c-Ha-Ras fused to the C-terminus (PAGFP-F). Note that PAGFP-F most likely becomes also palmitoylated, since the sequence, which is fused to PAGFP, also contains palmitoylatable cysteine residues ([@B4]). Bioinformatic analysis revealed two potential palmitoylation sites in addition to the farnesylation site (CSS-Palm 2.0; [@B43]). Thus PAGFP-F could serve as a reference protein for membrane attachment, which requires at least dual lipidation ([@B48]). The constructs were expressed in PC12 cells, which provide a well-established model for differentiating neurons. The GAP43 fusion proteins separated at an apparent molecular weight of ∼80 kDa ([Figure 1B](#F1){ref-type="fig"}). The retarded mobility compared with the calculated molecular weight (52.6 kDa) is in agreement with the fact that GAP43 alone separates at higher molecular weight than calculated ([@B6]). 3×PAGFP separated at an apparent molecular weight of ∼95 kDa, which makes it appropriate as a cytosolic control construct of similar size. PAGFP-F separated at 32 kDa, close to the calculated molecular mass. We did not observe major degradation, indicating that the constructs are stable within the cells. Endogenous GAP43 and the GAP43~wt~ and GAP43~S41A~ fusion proteins were detected by an antibody against GAP43 ([Figure 1B](#F1){ref-type="fig"}, middle, arrow). The antibody did not detect GAP43~S41D~, suggesting that the phosphomimicking mutation abolished antibody reactivity.

![Expression of PAGFP-tagged GAP43 constructs in neuronally differentiated PC12 cells. (A) Schematic representation of the PAGFP-tagged GAP43 constructs. PAGFP with a farnesylation signal (PAGFP-F) and 3×PAGFP were prepared as reference constructs. PAGFP is indicated as a green box, the IQ domain (position 30--52 in rat GAP43) containing the phosphorylation site (Ser-41) as a red box, and the farnesylation signal, which directs lipidation of PAGFP-F, as a blue box. Right, calculated relative molecular weights. (B) Immunoblots of lysates of transfected PC12 cells expressing the respective constructs. Blots were developed using anti-GFP (left and right) and anti-GAP43 antibody (middle). GFP-tagged constructs are indicated by arrowheads, endogenous GAP43 by an arrow. The phosphomimicking GAP43 construct is not recognized by the anti-GAP43 antibody (JP91), suggesting that mutation of Ser-41 to Asp blocks binding of the antibody. Numbers to the sides of the blots indicate molecular mass standards in kilodaltons. (C) Fluorescence micrographs of PC12 cells transfected with the respective GAP43 constructs and controls. Cells were treated with NGF for 6 d. Exogenous proteins were detected using anti-GFP antibody. Note the enrichment of the GAP43 constructs in the tip of the processes. Scale bar, 50 μm.](3284fig1){#F1}

To determine the intracellular localization of the different constructs at steady state, we performed immunocytochemical stainings from neuronally differentiated PC12 cells that had been transfected with the different constructs ([Figure 1C](#F1){ref-type="fig"}). All constructs showed ubiquitous staining patterns, with the GAP43 constructs being clearly present in the tip. We did not observe major morphological differences between cells that expressed the different GAP43 constructs as judged by their mean process lengths 6 d after transfection (40.4 ± 1.5, 43.2 ± 2.2, and 44.4 ± 2.3 μm for GAP43~wt~, GAP43~S41A~, and GAP43~S41D~, respectively; mean ± SEM, *n* = 134--269 processes from three or four independent experiments).

Phosphorylation at Ser-41 is required for plasma membrane association of GAP43
------------------------------------------------------------------------------

Previous experiments using detergent-extraction protocols suggested that GAP43 associates with the membrane skeleton in a phosphorylation-dependent manner ([@B38]). To determine a potential association of GAP43~wt~ and phosphorylation mutants with the cell periphery in living cells, we determined the distribution of GAP43-PAGFP constructs in living transfected PC12 cells. PAGFP was activated in the whole field of view, followed by confocal laser scanning microscopy (cLSM). GAP43~wt~ and GAP43~S41D~ showed clear enrichment at the periphery in single focal planes ([Figure 2A](#F2){ref-type="fig"}, left). In contrast, the phosphoblocking variant of GAP43 (GAP43~S41A~) was mostly present in the cytoplasm. Quantification by densitometric analysis of single *z*-stack images (for details see *Materials and Methods*) revealed that phosphorylation-mimicking GAP43 (GAP43~S41D~) exhibited significant higher and phosphorylation blocking GAP43 (GAP43~S41A~) significant lower peripheral enrichment than wild-type GAP43, consistent with the view that phosphorylation at Ser-41 is required for plasma membrane association ([Figure 2A](#F2){ref-type="fig"}, right).

![Phosphorylation at Ser-41 is required for plasma membrane association of GAP43. (A) High-resolution images of single focal planes of living PC12 cells expressing the constructs as indicated. Photoactivation was performed in the whole field of view before imaging. Right, quantitation of peripheral enrichment by densitometric analysis of single *z*-stack images (for details see *Materials and Methods*). Mean ± SEM, *n* = 29--35 cells from three of four independent experiments. \*\*\*Significantly different values compared with GAP43~wt~. Note that GAP43~S41D~-PAGFP exhibits higher and GAP43~S41A~-PAGFP lower peripheral enrichment than wild-type GAP43-PAGFP. Arrowheads indicate examples for obvious enrichment of GAP43~S41A~-PAGFP at the periphery. Scale bar, 10 μm. (B) Schematic representation of the plasma membrane fractionation assay to analyze the interaction of GAP43 with the neural plasma membrane (left). Immunoblots show the distribution of PAGFP-tagged GAP43 constructs (GFP), tubulin (tub), and transferrin receptor (TFR) in the cytosolic (cyt), membrane wash (mw), and plasma membrane (pm) fractions. Note that GAP43~wt~ is present in the cytosolic and pm fractions, whereas GAP43~S41A~ is mainly present in the cytosol and GAP43~S41D~ in the pm fraction. Detection of GAP43-PAGFP and endogenous GAP43 with a Ser-41 phosphorylation-specific antibody (anti-phosphoneuromodulin) indicates that phosphorylated GAP43 is mainly present in the pm fraction. (C) Image of a single focal plane of a living PC12 cell expressing PAGFP-F (top) and immunoblot showing the distribution of PAGFP-F (GFP), tubulin (tub), and transferrin receptor (TFR) in the indicated fractions. Note the high enrichment of PAGFP-F in the pm fraction. Scale bar, 10 μm. Numbers to the sides of the gel blots indicate molecular mass standards in kilodaltons (B, C). Statistical analysis was performed using Student\'s *t* test. \*\*\*, *p* \< 0.001.](3284fig2){#F2}

To distinguish between a direct plasma membrane association and binding to the membrane skeleton, we used a subcellular fractionation protocol based on magnetic sphere separation of surface-biotinylated cells. The procedure allows us to enrich for plasma membranes together with proteins of the associated membrane cortex (bound fraction; [Figure 2B](#F2){ref-type="fig"}, left; [@B34]; [@B16]). The bound fraction was further separated by a high-pH wash to selectively remove peripherally bound proteins (membrane wash) from a plasma membrane fraction (pm; [@B60]). As expected, a plasma membrane marker (transferrin receptor) was exclusively present in the pm fraction, whereas tubulin, which behaves under the conditions of fractionation as a cytosolic protein, was mostly present in the cytosol. A small portion of tubulin was also present in the pm fraction, which probably reflects the presence of lipid-modified tubulin, as reported earlier ([@B62]; [Figure 2B](#F2){ref-type="fig"}, right).

GAP43~wt~-PAGFP was present in both the pm and cytosol fractions, whereas the majority of GAP43~S41D~ was plasma membrane--associated at the conditions of separation. In contrast, only a small amount of GAP43~S41A~ was present in the pm fraction, which agreed well with its distribution in living cells ([Figure 2A](#F2){ref-type="fig"}). No GAP43 was observed in the membrane wash, indicating that the presence of GAP43 in the pm fraction was due to tight lipid interaction. Thus the data suggest a requirement for Ser-41 phosphorylation for the association of GAP43 with the plasma membrane. In agreement, plasma membrane--associated GAP43~wt~ was preferentially detected with an antibody that was specific for GAP43 phosphorylated at Ser-41 (*P*-GAP43; [Figure 2B](#F2){ref-type="fig"}, middle). Phosphorylated endogenous GAP43 was also highly enriched in the pm fraction ([Figure 2B](#F2){ref-type="fig"}, bottom), indicating that overexpression of GAP43 or presence of the PAGFP tag does not interfere with plasma membrane association of GAP43.

To confirm the use of PAGFP-F as a reference for a plasma membrane--associated protein, we also determined the distribution of PAGFP-F in living, transfected PC12 cells. PAGFP-F showed clear enrichment at the periphery in single focal planes ([Figure 2C](#F2){ref-type="fig"}, top) and in the pm fraction after subcellular fractionation ([Figure 2C](#F2){ref-type="fig"}, bottom), indicating preferential lipid interaction. The fact that PAGFP-F is highly enriched in the pm fraction also suggests that PAGFP-F exhibits lipid modifications in addition to farnesylation to mediate strong membrane attachment ([@B48]).

To determine whether phosphorylation of GAP43 at Ser-41 is sufficient to induce plasma membrane association, we created a palmitoylation-deficient GAP43 construct by mutating the two cysteine residues at positions 3 and 4 to serine (GAP43~C3,4S~; [@B32]) and also as a combination with the two phosphomutations at Ser-41. None of the three constructs showed detectable enrichment at the cell periphery in living cells ([Figure 3A](#F3){ref-type="fig"}, left). Quantification by densitometric analysis confirmed the absence of peripheral enrichment ([Figure 3A](#F3){ref-type="fig"}, right), indicating an absolute requirement for palmitoylation for plasma membrane association. The fact that all palmitoylation-deficient GAP43 constructs exhibited a significant lower peripheral enrichment than the respective palmitoylatable counterparts indicates that palmitoylation alone mediates some, albeit apparently weak, association with the plasma membrane, which is increased after phosphorylation. This is also detectable in the images of the single focal plane of the respective nonphosphorylatable but palmitoylatable GAP43~S41A~-expressing cells (e.g., arrows in [Figure 2A](#F2){ref-type="fig"}).

![Palmitoylation of GAP43 is required for membrane association. (A) Images of single focal planes of living PC12 cells expressing different PAGFP-tagged palmitoylation-deficient constructs (GAP43~C3,4S~) as indicated. Photoactivation was performed in the whole field of view before imaging. Right, quantitation of peripheral enrichment by densitometric analysis of single *z*-stack images. Mean ± SEM, *n* = 13--20 cells from two independent experiments. ^\#\#\#^Significantly different values compared with GAP43~wt~ or the respective phosphomutants without the C3,4S mutation ([Figure 2A](#F2){ref-type="fig"}, right). Note the complete absence of peripheral enrichment in all palmitoylation-negative mutants. Scale bar, 10 μm. (B) Quantitation of the palmitoylation state of GAP43 and the two phosphomutants by \[^3^H\]palmitate labeling. The value for GAP43~wt~ was set as 100%. Experiments were conducted two times with three biological repetitions. Mean ± SEM, three to five independent experiments. (C) Subcellular fractionation of PC12 cells that have been lentivirally transduced to express the different PAGFP-tagged GAP43 constructs as indicated. Immunoblot showing membrane (m) and cytosolic (c) fractions (top) and the respective quantitation (bottom). Blots were developed using anti-GFP antibody. Quantitation was performed by determining the ratio of the membrane (m) to total (m + c) signal after densitometric analysis. The value for GAP43~wt~ was set as 1.0. Mean ± SEM from three to five independent experiments. Numbers to the side of the gel blot indicate molecular mass standards in kilodaltons. Statistical analysis was performed using Student\'s *t* test. *p* values are as follows: \*, *p* \< 0.05 \*\*\*(^\#\#\#^), *p* \< 0.001.](3284fig3){#F3}

GAP43 palmitoylation might be dynamic, being potentially subject to cycles of addition and removal ([@B23]). To address the question of whether the extent of palmitoylation is different between the constructs, we created PC12 cells that stably expressed PAGFP-tagged GAP43~wt~, GAP43~S41A~, GAP43~S41D~, and GAP43~C3,4S~ by lentiviral transduction and determined the palmitoylation state by a radioactive labeling approach. As expected, GAP43~C3,4S~ yielded only background levels, confirming that the C3,4S mutations block palmitoylation ([Figure 3B](#F3){ref-type="fig"}). We did not detect a major difference in the extent of palmitoylation between GAP43~wt~ and the phosphorylation-deficient GAP43~S41A~ mutant despite our finding that GAP43~S41A~ was much less associated with the plasma membrane.

The results could indicate that whereas palmitoylation generally mediates membrane association, phosphorylation could serve as a switch to direct palmitoylated GAP43 predominantly to the plasma membrane. To test this hypothesis, we used a subcellular fractionation protocol, which separates total membrane-associated GAP43 from the cytosolic pool. GAP43~C3,4S~ was almost completely cytosolic, confirming that palmitoylation is required for membrane interaction ([Figure 3C](#F3){ref-type="fig"}). Remarkably, the pattern in total membrane association closely resembled palmitoylation of GAP43~wt,~ GAP43~S41A~, and GAP43~S41D~, confirming that general membrane association is determined by the palmitoylation level. We also observed that the phosphomimicking variant GAP43~S41D~ exhibited a significant increase in palmitoylation, as well as membrane association. Although this could suggest that phosphorylation of Ser-41 increases membrane association via an increase in the level of palmitoylation, it could also result from the fact that palmitoylation is restricted to membranes and that therefore proteins with a long residence time at the membrane have a higher probability to be palmitoylated. It needs also to be taken into account that \[3H\]palmitate labeling is complex and depends on integrating rates of palmitoylation, rates of protein synthesis, rates of depalmitoylation, and rates at which the label equilibrates into cellular palmitoyl-CoA pools.

Taken together, the data suggest that phosphorylation at Ser-41 provides a switch to induce tight plasma membrane association of palmitoylated GAP43, which indicates a complex interplay between palmitoylation and phosphorylation.

Plasma membrane association decreases diffusion of GAP43 in the cell body and neuritic shaft
--------------------------------------------------------------------------------------------

To determine whether plasma membrane association affects the intracellular mobility of GAP43, we performed photoactivation experiments in the cell body and in processes of neuronally differentiated cells. Photoactivation was performed by a laser flash at 405 nm in a 5-μm spot, and GFP fluorescence was followed by time-lapse imaging at an excitation wavelength of 488 nm as described previously ([@B59]). Photoactivated GAP43~wt~-PAGFP quickly dissipated within the cell and showed partial association with the periphery both in the cell body and the process, indicative for plasma membrane association of a subpopulation ([Figure 4A](#F4){ref-type="fig"}, arrowheads). To quantitatively analyze protein mobility, we recorded fluorescence decay in activated regions in the cell body and middle of neurites over time and plotted the result. Total fluorescence did not decrease with time, confirming high photostability of PAGFP at the conditions of imaging (example shows recording in the cell body; [Figure 4B](#F4){ref-type="fig"}). Thus fluorescence decay after photoactivation (FDAP) directly reflected differences in the mobility of the activated proteins.

![Plasma membrane association decreases diffusion of GAP43 in the cell body and neuritic shaft. (A) Time-lapse microscopy of PC12 cells transfected with GAP43~wt~-PAGFP after fluorescence photoactivation in the cell body (top) or in the middle of a process (bottom). The position of photoactivation is indicated by a red circle in the preactivation image (pre). Arrowheads mark regions where plasma membrane association is evident. Scale bar, 10 μm. (B) FDAP of cells expressing GAP43 constructs (top) or reference constructs (bottom) after photoactivation in the cell body. The plots represent the fraction of fluorescence measured in the activated region and total fluorescence of cells. FDAP is fastest with GAP43~S41A~-PAGFP and 3×PAGFP, indicating quick dissipation of the cytsosolic constructs. FDAP is slowest with GAP43~S41D~-PAGFP and PAGFP-F, which exhibit plasma membrane association. GAP43~wt~-PAGFP exhibits intermediate FDAP, reflecting partial binding to the plasma membrane. Mean ± SEM, *n* = 10--39. (C) Determination of diffusion constants after modeling of FDAP curves as shown in B. Diffusion in the cell body was determined only for the plasma membrane--associated proteins since the geometry of activation did not permit modeling of the dissipation of cytosolic proteins. Mean ± SEM. \*^,^\*\*\*Significantly lower values compared with the cytosolic reference protein (3×PAGFP); ^o^significantly lower value compared with the diffusion of the same construct in the process. Statistical analysis was performed using Student\'s *t* test. *p* values are as follows: \*^(o)^, *p* \< 0.05 \*\*\*, *p* \< 0.001.](3284fig4){#F4}

We observed that the preferentially plasma membrane--associated phosphomimicking GAP43 mutant (GAP43~S41D~) showed slowest decay, whereas the mostly cytoplasmic phosphoblocking GAP43 mutant (GAP43~S41A~) showed fastest decay. GAP43~wt~ displayed intermediate FDAP ([Figure 4B](#F4){ref-type="fig"}, top). Thus the data indicate that the extent of plasma membrane association determines the mobility of GAP43 in living cells. In agreement with this hypothesis, we observed that FDAP curves for the plasma membrane--associated reference protein (PAGFP-F) were very similar to those for the plasma membrane--associated GAP43 mutant, whereas a purely cytosolic construct (3×PAGFP) distributed more like GAP43~S41A~ ([Figure 4B](#F4){ref-type="fig"}, bottom).

To describe quantitatively local protein mobility, we calculated diffusion constants of the different constructs. Diffusion constants were considered as effective quantities, and influences from cell compartments were not taken into account (see *Materials and Methods* for details). For processes, one-dimensional diffusion was assumed, which is justified by the fact that activation occurs over the full width of the process, and reflection at the tip and the sink effect of the cell body were taken into account. Diffusion constants of plasma membrane--associated proteins (PAGFP-F and GAP43~S41D~-PAGFP) were also calculated in the cell body, where two-dimensional diffusion could be assumed. Owing to the complex morphology of the cell soma, we refrained from calculating diffusion constants for cytoplasmic constructs in this compartment.

Diffusion constants were slightly lower for the plasma membrane--associated constructs in the cell body compared with neurites, which reached significance for PAGFP-F and might reflect minor differences in the membrane composition ([Figure 4C](#F4){ref-type="fig"}). However, in general, the numbers fit well with previous data on the diffusion of plasma membrane--associated proteins (e.g., 0.2--0.5 μm^2^/s for Thy-1 in fibroblast and lymphoid cells; [@B21]), demonstrating that our modeling approaches were adequate. In neurites, we observed a significant decrease in the diffusion constant of the plasma membrane--associated constructs compared with the cytosolic reference protein (3×PAGFP). With respect to the effect of Ser-41 phosphorylation, we observed approximately fourfold difference in the diffusion constants of GAP43~S41D~ versus GAP43~S41A~, further confirming that plasma membrane association decreases diffusion of GAP43 in living neuronal cells.

Trapping in growth cones is independent of GAP43 phosphorylation
----------------------------------------------------------------

Regulation of protein mobility by dynamic plasma membrane association may also contribute to the anchorage of proteins in specific compartments of a neuron, such as the growth cone. To test this hypothesis, we determined the retention of GAP43, the different phosphomutants, and the two reference proteins in the cell body, the process shaft, and the tip of processes using spatially restricted photoactivation experiments ([Figure 5](#F5){ref-type="fig"}, top). Retention was quantified by determining the fraction of the fluorescent protein population in the activated segment 10 s after photoactivation (see *Materials and Methods*).

![Retention of GAP43 constructs differs in the cell body, the process shaft, and the tip of processes. Top, schematic representation of the position of photoactivation in neuronally differentiated PC12 cells. Bottom, fractions of fluorescence as indicator for the retention at the respective position. Note that retention correlates with the ability of the GAP43 constructs to interact with the plasma membrane except at the process tip. Mean ± SEM, *n* = 10--39.](3284fig5){#F5}

The plasma membrane--associated reference protein (PAGFP-F) exhibited significantly increased retention compared with the soluble control (3×PAGFP) in all compartments ([Figure 5](#F5){ref-type="fig"}, bottom), indicating that association with the plasma membrane generally increases retention. Accordingly, the membrane-associated GAP43 mutant (GAP43~S41D~) showed increased retention compared with the cytoplasmic GAP43 mutant (GAP43~S41A~) in the cell body and the process shaft ([Figure 5](#F5){ref-type="fig"}, left and middle). Surprisingly, no difference between GAP43~wt~ and the phosphomutants was observed in the tip of processes. Potential mechanisms that increase tip retention could include lipidation-induced interactions or anterograde axonal transport, which would lead to constant flow toward the end of processes.

Sorting of GAP43 to growth cones requires palmitoylation and active transport
-----------------------------------------------------------------------------

Immunofluorescence micrographs indicated that GAP43 constructs were clearly present in the tip of growth cones ([Figure 1C](#F1){ref-type="fig"}). To follow the kinetics of potential sorting to the tip, we performed experiments in which we photoactivated the somatic population of GAP43 constructs and followed their distribution into neurites by long-term time-lapse fluorescence microscopy ([Figure 6A](#F6){ref-type="fig"}). Ten minutes after photoactivation, GAP43~wt~-PAGFP and both phosphomutants could be detected in individual growth cones. Pronounced labeling of process tips was observed after 50 min for all constructs and persisted over time ([Figure 6A](#F6){ref-type="fig"}, arrowheads). To determine sorting efficiency quantitatively, we recorded fluorescence increase in the distal process ([Figure 6B](#F6){ref-type="fig"}, green box) by time lapse imaging after photoactivation in the cell body ([Figure 6B](#F6){ref-type="fig"}, red box). Plots were normalized to the maximum intensity for the respective construct (set as 1.0) and time constants (τ) were calculated.

![Sorting of GAP43 to growth cones is independent of phosphorylation but requires palmitoylation and active transport. (A) Long-term imaging of neuronally differentiated PC12 cells expressing GAP43 constructs after photoactivation of the cell body. The region of activation is indicated by a red square in the preactivation image (pre). Note that all GAP43 constructs can be detected in the tips (arrows) already 10 min after photoactivation. Scale bar, 50 μm. (B) Quantification of the kinetics of GAP43 sorting to growth cones. Increase of tip fluorescence was recorded as schematically indicated in the distal 10 μm of processes (green box) after photoactivation of the cell body (red box) from exemplary experiments as shown in B. Mean ± SEM, *n* = 6--16. Time constants τ (mean ± SEM) are given for the different constructs. \*\*\*Significantly different values compared with GAP43~wt~. Note that sorting does not differ between the phosphoblocking S41A and the phosphorylation-mimicking S41D construct. Statistical analysis was performed using Student\'s *t* test. \*\*\*, *p* \< 0.001.](3284fig6){#F6}

GAP43~wt~ appeared in the tip region with a τ of 5.8 min ([Figure 6B](#F6){ref-type="fig"}, right, top), which was ∼10 times faster than PAGFP-F (τ = 66.4 min), indicating efficient sorting of GAP43 to the growth cone. To test whether plasma membrane association of GAP43 contributes to sorting efficiency, we performed similar experiments with GAP43~S41D~ and GAP43~S41A~ phosphomutants. The two constructs exhibited similar time constants, indicating that sorting efficiency is not affected by the phosphorylation state of Ser-41. Note, however, that τ of the phosphomutants was slower by a factor of approximately three than the time constant of GAP43~wt~, suggesting that phosphorylation-mediated membrane reaction (i.e., dynamic phosphorylation-mediated plasma membrane interaction) increases sorting efficiency.

To test for a role of palmitoylation in sorting to the growth cone, we tested the palmitoylation-deficient GAP43 mutant (GAP43~C3,4S~). As reported previously and also shown in [Figure 4A](#F4){ref-type="fig"}, the C3,4S mutation rendered GAP43 to be uniformly distributed in the cytosol without apparent enrichment in the periphery. GAP43~C3,4S~ was highly mobile in the cells (note that τ is in range of seconds), closely reflecting the behavior of 3×PAGFP ([Figure 6B](#F6){ref-type="fig"}, left, bottom), indicating pure diffusion-guided dissipation of nonpalmitoylated GAP43.

The finding that GAP43 reached process tips much faster than a plasma membrane--associated reference protein could argue for involvement of fast axonal transport. To test this hypothesis, we treated cells with the drug brefeldin A immediately before imaging. At these conditions, brefeldin A inhibits protein secretion at an early step in the secretory pathway, thus providing a tool to inhibit membrane transport ([@B25]). In the presence of brefeldin A, the time constant for sorting of GAP43 to the tip decreased approximately ninefold to a value close to PAGFP-F as plasma membrane--associated reference protein ([Figure 6B](#F5){ref-type="fig"}, right, bottom), indicating that fast axonal transport contributes to efficient sorting of GAP43.

Directed transport of GAP43 by transient piggybacking on exocytic vesicles
--------------------------------------------------------------------------

Pharmacologic inhibition of transport indicated that a fraction of GAP43 is anterogradely transported. If true, a flux of GAP43 toward the tip of the process should be observed. To test this hypothesis, we photoactivated a population of GAP43 in the middle of the process and recorded changes in the fluorescence distal to and proximal from the center of activation ([Figure 7A](#F7){ref-type="fig"}, top). Flux should then become evident by a ratio of distal/proximal fluorescence higher than one in the majority of the processes. Indeed, we observed increased distal/proximal ratios for GAP43~wt~, which became significant at 25 min ([Figure 7A](#F7){ref-type="fig"}, middle). No flux was observed with the cytosolic control protein (3×PAGFP). Treatment with brefeldin A abolished distal flux, supporting a requirement for vesicle transport in trafficking of GAP43. Distal flux was also observed with the phosphoblocking GAP43 construct (GAP43~S41A~), supporting that phosphorylation-mediated membrane reaction is not required for transport of GAP43 ([Figure 7A](#F7){ref-type="fig"}, bottom, right).

![Directed transport of GAP43 by transient piggybacking on exocytic vesicles. (A) Flux analysis of photoactivated protein in processes of transfected PC12 cells. Top, schematic showing the region of photoactivation (gray box) and the position of the recording regions distal and proximal from the center of activation. Bottom, ratios of distal to proximal fluorescence at different times after activation. Mean ± SEM, *n* = 7--9. The percentage of processes that show higher distal than proximal fluorescence is given in the boxes. \*Significantly higher values compared with 1.0. (B) TIRF image of a part of a cell body of a living PC12 cell expressing GAP43-HaloTag (labeled with HTL-OG; green) and synaptophysin-mCherry (red). The focal plane was adjusted in such a way as to visualize a region above the cellular contact site, and the nucleus is visible at the right. Note the presence of green and red structures with vesicular appearance. Note that some structures show yellow fluorescence (arrowheads) indicative of colocalization of GAP43 with vesicular structures. Scale bar, 10 μm. Bottom, time series of TIRF micrographs at the transition of a neurite shaft (n.s.) to the growth cone (g.c.). An example of a particle showing colocalization of GAP43 and synaptophysin, which can be tracked for several seconds, is shown. Scale bar, 10 μm (left), 5 μm (right). The table gives numbers for individual tracking events with colocalization of HTL-OG--labeled GAP43-HaloTag and synaptophysin-mCherry. Note that double-labeled particles move with an average speed of 1.5 ± 0.2 μm/s (*n* = 10), similar to the speed of fast axonal transport. Statistical analysis was performed using Student\'s *t* test. \*, *p* \< 0.05.](3284fig7){#F7}

To visualize potential colocalization of GAP43 with moving vesicles, we prepared a GAP43 construct with a carboxy-terminal HaloTag, which allows specific and irreversible posttranslational protein labeling with synthetic ligands, yielding high fluorescence intensity ([@B33]). Cells were transfected to express mCherry-tagged synaptophysin, a membrane marker of synaptic vesicles and synaptic-like microvesicles ([@B42]). As reported previously, fluorescent vesicles could be observed in the cell body, processes, and growth cone--like structures, which are likely to reflect a mixture of endocytic and exocytic vesicles ([Figure 7B](#F7){ref-type="fig"}; [@B22]). Mobility of GAP43- or synaptophysin-positive structures was observed, and, in some cases, costaining and comobility of vesicular structures could be detected ([Figure 7B](#F7){ref-type="fig"}, bottom). Tracking of some individual costained structures was possible for several seconds, and distal movement occurred over distances from 3 to 6 μm ([Figure 7B](#F7){ref-type="fig"}, right), suggesting transport of GAP43 via association with exocytic vesicles. Determination of mean velocity of the costained structures revealed an average speed of 1.5 μm/s, similar to the speed of fast axonal transport in cultured neurons ([@B22]). The data indicate that a fraction of GAP43 exhibits fast axonal transport, presumably by transient piggybacking on exocytic vesicles.

Simulations
-----------

Our experimental data provided evidence that the distribution of GAP43 is guided by diffusion, phosphorylation-mediated plasma membrane association, and transport. To dissect the contribution of the different mechanisms in sorting of GAP43 to the growth cone, we developed a simulation based on three factors: 1) diffusion in the plasma membrane; 2) membrane reactions, that is, phosphorylation-mediated exchange between plasma membrane--bound and cytoplasmic protein; and 3) axonal transport of a fraction of the protein ([Figure 8, A and B](#F8){ref-type="fig"}). The simulation showed that diffusion in the plasma membrane with a value that we had experimentally determined for PAGFP-F (∼0.4 μm^2^/s) as *sole* mechanism of distribution results in a high time constant for appearance in the growth cone. Such behavior is in agreement with the distribution of PAGFP-F as a plasma membrane--associated reference protein (red curve in [Figure 8C](#F8){ref-type="fig"} and respective curve in [Figure 6B](#F6){ref-type="fig"}). Inclusion of the occurrence of membrane reactions with a pseudoequilibrium constant similar to what we observed for GAP43~wt~ (*K*~d~\* = 1 \[50% bound\]) and diffusion of the cytosolic component with a value that we had experimentally determined for 3×PAGFP resulted in the reduction of τ by a factor of approximately four ([Figure 8C](#F8){ref-type="fig"}, dashed blue line). Addition of a transport component led to a further decrease of τ by a factor of two, resulting in kinetics similar to the behavior of GAP43~wt~ (blue curve in [Figure 8C](#F8){ref-type="fig"} and respective curve in [Figure 6B](#F6){ref-type="fig"}). Remarkably, a fraction of only 10% of the molecules undergoing fast axonal transport was sufficient to simulate the experimental data for sorting of GAP43.

![Simulation of kinetic curves for sorting of proteins at different conditions. (A) Table showing the parameters used for the simulations. We used values that we experimentally determined in this study. (B) Schematic outline of the model. Technical details are given in *Materials and Methods*. (C) Simulated kinetic curves for sorting of the proteins at different conditions using the values given in A and the model shown in B. Note that a combination of diffusion, phosphorylation-regulated membrane reaction, and transport of a small fraction (10%) of protein with the speed of fast axonal transport suffices to simulate the experimental data for sorting of GAP43~wt~ (blue lines in C vs. [Figure 6B](#F5){ref-type="fig"}).](3284fig8){#F8}

DISCUSSION
==========

Posttranslational modifications can dramatically change the function and interactions of cytosolic proteins and are likely to contribute to protein sorting. This is of particular importance for highly polarized cells such as neurons. An instructive example is GAP43, which is synthesized on free ribosomes in the neuronal cell body, is susceptible to phosphorylation and lipidation, and becomes highly enriched in the tips of extending neurites. To scrutinize how phosphorylation and lipidation mediate sorting of GAP43, we used a combination of biochemical, genetic, and imaging approaches. Our results are summarized in [Figure 9](#F9){ref-type="fig"} and demonstrate a complex interplay of phosphorylation and palmitoylation in plasma membrane targeting and sorting of GAP43. In particular, we showed that 1) phosphorylation at Ser-41 directs palmitoylated GAP43 to the plasma membrane, 2) plasma membrane association decreases diffusion of GAP43 in the cell body and neuritic shaft, and 3) S-palmitoylation tags GAP43 for global sorting by inducing piggybacking on exocytic vesicles. Furthermore, we showed that plasma membrane association exhibits an absolute requirement for palmitoylation and that palmitoylation-mediated sorting to the growth cone is increased by phosphorylation-mediated membrane reaction.

![Schematic representation summarizing our results, demonstrating the interplay of phosphorylation (P) and palmitoylation (L) in plasma membrane targeting and sorting of GAP43. The data indicate that phosphorylation at Ser-41 serves as a switch to regulate local diffusion by inducing plasma membrane association of lipidated GAP43, whereas palmitoylation tags a fraction of proteins for global sorting by inducing piggybacking on exocytic vesicles.](3284fig9){#F9}

Previous results and our data indicate an important role of lipidation in sorting of GAP43. However, it is still a matter of debate to what extent GAP43 is palmitoylated in neural cells. A previous mass spectroscopic study reported a surprisingly low stoichiometry of palmitoylation and found only ∼35% of total GAP43 being lipidated in PC12 cells ([@B30]). It should be taken into account, however, that direct analysis of palmitoylation is difficult, relating to the chemical survival of the thioester-linked acyl moiety and the potential loss of the modification during isolation due to the presence of depalmitoylases. These issues may bias detection of nonpalmitoylated versus palmitoylated GAP43 and could argue for a higher palmitoylation stoichiometry. In fact, another study did not find evidence of free cysteines in GAP43, implying high palmitoylation stoichiometry ([@B50]). In the same study, it was demonstrated that GAP43 in isolated growth cones could be labeled with \[3H\]palmitate, arguing for local palmitoylation/depalmitoylation dynamics. Thus GAP43 palmitoylation, like that of PSD-95, could be dynamic, being potentially subject to cycles of addition and removal ([@B23]). With respect to the requirement of lipidation for plasma membrane association, it has been suggested that, once initial binding has taken place, palmitate chains might not longer be needed and can be removed ([@B31]), which could explain the presence of membrane association despite a potentially low general palmitoylation level. It should be noted, however, that our fractionation experiments, which demonstrate binding of GAP43 after a high-pH wash, which is known to remove peripherally bound proteins, argue in favor of a lipid--lipid interaction of a palmitoylated protein.

Previous electron microscopic studies revealed that the majority of GAP43 is associated with the plasma membrane and that only ∼25% of GAP43 is associated with vesicles ([@B57]). This poses the question of how GAP43 gets sorted to the distal process under conditions in which only a minority is localized to vesicles at steady state. We showed that conditions that block vesicle transport or abolish palmitoylation prevent distal flux of GAP43, indicating vesicle-mediated transport of palmitoylated GAP43. TIRF microscopy confirmed translocation of a fraction of GAP43 with individual exocytic vesicles, probably via a piggybacking mechanism. Of interest, even the predominantly cytoplasmic phosphoblocking GAP43 construct (GAP43~S41A~) exhibited membrane binding and some enrichment with the periphery, suggesting that lipidation by itself induced weak plasma membrane interaction, which suffices for piggybacking. Our simulation approach revealed that a fraction of only 10% of the molecules undergoing fast axonal transport was sufficient to simulate the experimental data for sorting of GAP43 to the growth cone. Thus, even at a very low steady-state level of palmitoylation or weak plasma membrane interaction, efficient sorting to growth cones could be expected. Remarkably, transport was not dependent on Ser-41 phosphorylation but increased when phosphorylation was possible, indicating that phosphorylation-mediated exchange between a plasma membrane--bound and a cytoplasmic state increases sorting efficiency.

We showed that phosphorylation at Ser-41 is required for plasma membrane association of palmitoylated GAP43 in neuronal cells. However, how phosphorylation affects membrane association is unclear. Binding of GAP43 to the plasma membrane appears to be mediated by a combination of electrostatic interactions and lipidation. Previous results implied three basic residues (Arg-6, Arg-7, and Lys-9) to be involved in membrane interaction ([@B12]), and palmitoylation might help to align these residues with the membrane. GAP43 is phosphorylated by PKC at Ser-41, which is the only PKC site and is located in the IQ domain (amino acids 30--52), an extremely basic unit with α-helical secondary structure ([@B10]). Phosphorylation at Ser-41 disrupts the structure of the IQ domain, leading to a conformational change of the protein ([@B53]). It has been shown that Ser-41 phosphorylation affects binding of the IQ domain to calmodulin ([@B9]; [@B10]) and induces release of calmodulin from GAP43, which may permit membrane association. In turn, dephosphorylation may induce calmodulin binding and subsequent release from the membrane. In addition, it has been shown that GAP43 directly binds to acidic phospholipids, including phosphoinositide (PI) lipids, by electrostatic interaction though its IQ domain, which might guide plasma membrane interaction ([@B20]; [@B27]). However, phosphorylation of Ser-41 would be expected to weaken the membrane interaction, which is opposite to our observation and would imply that electrostatic interaction with PI lipids is not directly responsible for phosphorylation-induced plasma membrane association of GAP43. It is also possible that Ser-41 phosphorylation plays a role in regulating palmitoylation/depalmitoylation dynamics of GAP43, perhaps by blocking interaction with the putative depalmitoylase. Alternatively, phosphorylation could enhance the membrane interaction by leading to an increased palmitoylation. We did not observe a difference in the palmitoylation level of the mostly cytosolic phosphoblocking mutant (GAP43~S41A~) and GAP43wt, which might argue against a scenario in which phosphorylation regulates membrane interaction through changes in the palmitoylation level.

We found that plasma membrane association had a major effect on the local mobility of GAP43, as indicated by a change in the diffusion constant by a factor of four. Thus changes in the extent of phosphorylation at Ser-41 have the potential to affect local mobility of GAP43 in a temporally and spatially defined manner. It is known that PKC phosphorylates GAP43 at Ser-41 and that phosphorylation of this residue can be stimulated by chemotrophic factors and cell adhesion molecules ([@B37]). Phosphorylated Ser-41 can then be dephosphorylated by Ca^2+^-independent phosphatases type 1 and 2A and by the calcium/calmodulin-dependent phosphatase calcineurin. Thus phosphorylation/dephosphorylation of GAP43 at Ser-41 could provide a physiological mechanism to regulate the mobility of GAP43 in response to extracellular cues. In turn, disturbance of the phosphorylation dynamics at Ser-41 could contribute to abnormal GAP43 localization and behavior. In fact, evidence exists that translocation of PKC is impaired during aging and in several neurodegenerative diseases ([@B40]) and that the level of PKC is decreased by 50% in particulate (i.e., putatively membranous) fractions of Alzheimer\'s disease (AD) versus control brains ([@B11]). This could explain why membrane-associated GAP43 is reduced in regions of degeneration in AD patients ([@B36]). However, whether phosphorylation-mediated mislocalization of GAP43 directly contributes to neurodegeneration or represents a side effect of disturbed phosphorylation/dephosphorylation kinetics remains to be determined.

MATERIALS AND METHODS
=====================

Materials and antibodies
------------------------

Chemicals and antibodies were purchased from Sigma-Aldrich (Deisenhofen, Germany) unless stated otherwise. Cell culture media and supplements were obtained from Sigma-Aldrich and Invitrogen (Gaithersburg, MD); culture flasks, plates, and dishes from Thermo Fisher Scientific (Schwerte, Germany); and primers from Biomers (Ulm, Germany) or Thermo Fisher Scientific. Brefeldin A was purchased from AppliChem (Darmstadt, Germany), and HaloTag Oregon Green Ligand (HTL-OG) was obtained from Promega (Madison, WI). The following antibodies were used: anti-GFP (rabbit polyclonal; Millipore, Billerica, MA), anti-phosphoneuromodulin (rabbit antiserum; Upstate, Lake Placid, NY), anti-tubulin (DM1A; mouse monoclonal), and anti-TRF (mouse monoclonal; Invitrogen). In addition, a novel mouse monoclonal antibody against total GAP43 was used, which we generated using an immunological screen against proteins of the membrane skeleton (clone JP91; the antibody had been prepared as described in [@B41]). As secondary antibodies, we used anti-rabbit Cy3- and peroxidase-conjugated anti-mouse and anti-rabbit antibodies (Jackson Immuno­Research Laboratories, West Grove, PA).

Construction of expression vectors, transfections, and lentiviral infections
----------------------------------------------------------------------------

Rat GAP43 cDNA ([@B24]) was generated by reverse transcriptase (RT)-PCR using SuperScript One-Step RT-PCR Kit (Invitrogen) from RNA extracts of PC12 cells using the following primers (5′ to 3′; sense primers are listed first): atgctgtgctgtatgagaagaaccaaacag and tcaggcatgttcttggtcagcctcggg; for cloning; restriction sites for *Afe*I and *Age*I were added using primers cttggggccagcgctatgctgtgctgtatgagaagaacc and cttcaccggaccggttcaggcatgttcttggtcagcctc. The resulting PCR product was sequentially cut with the respective enzymes (Fermentas, St. Leon-Rot, Germany) and cloned into a pRc/CMV-based pPAGFP(A206K)-N1 expression vector containing a cytomegalovirus (CMV) promoter and kanamycin and neomycin resistance genes. A206K mutation to prevent dimerization of PAGFP was included before using cctgagccaccagtccaaactgagcaaagacccc primer ([@B63]). Mutations at Ser-41 were included via site-directed mutagenesis using gcaaccaaaattcaggctgcgttccgtggacacataacaagg for S41A and gcaaccaaaattcaggctgacttccgtggacacataacaagg for S41D. The C3,4S mutation was generated via site-directed mutagenesis using gctagcgctatgctgtcctctatgagaagaaccaaacagg primer. To construct a GAP43-HaloTag fusion, restriction sites for *Eco*RI and *Eco*RV were added using primers cagatccgctgatatcatgctgtgctgtatgag and gcagaattcaagcttatgttcttgg. The resulting PCR product was sequentially cut with the respective enzymes (Fermentas) and cloned into pSems-Halo-1-26m ([@B61]). To construct pPAGFP-F, we used pEGFP-F (Clontech/Takara, Shiga, Japan), which contains the 20--amino acid farnesylation signal from c-Ha-Ras fused to the C-terminus of enhanced GFP (EGFP), and exchanged the EGFP part against PAGFP from pPAGFP(A206K)×1-C1. Mouse synaptophysin-mCherry was synthesized by custom gene synthesis (Life Technologies, Darmstadt, Germany) containing restriction sites for *Bam*HI and *Xba*I and cloned into pCDNA3.1(+) (Invitrogen). Lentiviral vectors were constructed in L26 FSy(1.1)GW-EGFP ([@B14]) by replacing the EGFP part with GAP43wt-, GAP43S41A-, GAP43S41D-, and GAP43C3,4S-PAGFP sequence. All constructs were confirmed by sequencing.

Transfections of PC12 cells were performed with Lipofectamine 2000 (Invitrogen) essentially as described previously ([@B16]). For production of lentivirus, human embryonic kidney cells 293FT (Invitrogen) were transfected with the expression vector, and two helper plasmids and viral particles from the supernatant were concentrated by ultracentrifugation as described previously ([@B5]).

Cell culture and drug treatment
-------------------------------

PC12 cells were cultured in serum-DMEM as described previously ([@B16]). Undifferentiated cells were plated on 35-mm poly-[l]{.smallcaps}-lysine-- and collagen-coated glass-bottom culture dishes (MatTek, Ashland, MA) at 1 × 10^3^ cells/cm^2^ and cultured in DMEM with 1% (vol/vol) serum. Cells were neuronally differentiated by addition of 100 ng/ml 7S mouse nerve growth factor (mNGF; Alomone Labs, Munich, Germany) for 4--6 d, with a medium change after 2--3 d. Before imaging, the medium was exchanged against the same medium containing DMEM without phenol red. Brefeldin A was added to the culture directly before imaging at a final concentration of 5 μg/ml. For TIRF imaging, cells were plated on 24-mm PLL-PEG-RGD ([@B55])--coated glass coverslips (No. 1; VWR, Darmstadt, Germany).

Immunocytochemistry
-------------------

Cells were fixed with 4% (wt/vol) formaldehyde in phosphate-buffered saline (PBS), and staining was performed essentially as described earlier ([@B16]) in PBS containing 1% (wt/vol) bovine serum albumin using the respective antibodies.

Photoactivation and live-cell imaging
-------------------------------------

Imaging was performed on a Nikon laser scanning microscope (Nikon Eclipse TE2000-U inverted; Nikon, Tokyo, Japan), equipped with a C1 confocal laser scanning unit, argon (488 nm), helium/neon (543 nm), and blue diode (405 nm) lasers and EZ-C1 software essentially as described earlier ([@B59]). Microscope objectives used were an oil-immersion Nikon Plan Fluor 60× (numerical aperture \[NA\], 1.4) ultraviolet-corrected (VC) objective. The microscope was enclosed in an incubation chamber maintained at 37°C and 5% CO~2~ (Solent Scientific Limited, Fareham, UK). Images were collected at 256 × 256 pixels. Photoactivation was performed with the 405-nm blue diode with two scans at a pixel dwell time of 4.08 μs. Subsequent frames were obtained at a frequency of 1 frame/s (short-term imaging) or 1 frame/min (long-term imaging), and 112 frames were collected per experiment. It was verified by software tools that no pixels in the initial frames were saturated, and movies including the "preactivation image" were created in 12-bit format. For high-resolution imaging of optical slices, *z*-stacks of living cells were collected at 1024 × 1024 pixels with a step size of 0.5 μm immediately after whole-cell activation.

TIRF microscopy was performed using an Olympus excellence cell⊥TIRF microscope equipped with 405-, 488-, 561-, and 647-nm lasers, as well as a backilluminated electron-multiplied charge-coupled device camera (C9100-13; Hamamatsu, Hamamatsu City, Japan). A 150× (NA: 1.45; UAPON; Olympus, Tokyo, Japan) oil objective was used for TIRF excitation. The excitation beam was reflected into the objective by a quad-line dichroic beam splitter for reflection at 405, 488, 568, and 647 nm (Di01 R405/488/561/647; Semrock, Rochester, NY). The emitted light from the sample was filtered using a quad-band bandpass filter (FF01 446/523/600/677; Semrock). Image series with two colors were acquired using alternating excitation.

Image analysis
--------------

For quantification of peripheral enrichment by densitometric analysis, optical slices of living cells, which were collected after whole-cell activation, were evaluated. Slices in the middle of the *z*-stacks were selected and grayscale intensities in 2-μm disks determined using Fiji software ([@B46]). Maximal intensities from five randomly chosen positions at the periphery, the central portion, and the surrounding background, respectively, were determined per cell and averaged. The background value was subtracted and peripheral enrichment was defined as (signal periphery)/(signal center).

To determine the kinetics of tip fluorescence after activation in the cell body, we evaluated movies from long- or short-term imaging experiments. From all frames, the zero-level ("preactivation intensity") was subtracted in order to exclude the preactivation fluorescence. Raw curves were generated by determining the fluorescence intensity in the distal 10 μm of the processes, then normalized to the corresponding saturation value by fitting it to a simple exponential recovery profile, *A*(1 − *e*^−*t*/τ^), where *A* denotes the saturation amplitude of the curve and τ the recovery time. Then we used *A* to normalize the raw curves, and we averaged all curves.

To determine the retention of photoactivated proteins, we determined *I*~t~/*I*~tot~ from the fluorescence intensity at time *t* after activation in the activated segment and the fluorescence signal from total photoactivation. This value reflects the immobile fraction of the activated population in the activated segment at time *t*.

Flux analysis was performed using a program developed in Matlab as described in [@B59]. Appearance of photoactivated protein populations was recorded in 5-μm spots 10 μm distal and 10 μm proximal from the center of activation, as shown in [Figure 7A](#F6){ref-type="fig"}, top.

Determination of diffusion constants
------------------------------------

The diffusion constant, *D*, was evaluated by determining the decay of fluorescence after activation of PAGFP at a suitable fixed position *R*~A~ by time-lapse scans. The normalized signal is called FDAP in [Figure 4B](#F3){ref-type="fig"}, that is, the fluorescence intensity *I*(*R*~A~, *t*) divided by *I*(*R*~A~, *t = 0*), the value of the first frame after activation. If *R*~A~ was located in a process, the expressions for *I*(*t*) reported in [@B59] and [@B17] were applied. This approach is based on one-dimensional diffusion, which is justified because activation occurs over the full width of the process. Reflection at the tip and the sink effect at the soma transition were taken into account by the "method of images." Diffusion constants of membrane-associated proteins PAGFP-F and GAP43~S41D~-PAGFP were further determined in the cell body (see table in [Figure 4C](#F3){ref-type="fig"}), where the one-dimensional approach is clearly inadequate. In the cell body, two-dimensional diffusion was observed for these species if the activation was done in a spot near the basal plane (with coordinates *x*, *y*) and if this spot was well separated from the cell border. With *ρ*(*x*, *y*) being the density of the activated species in the first frame after activation at position *x*~A~, *y*~A~, analysis of the intensity initial distribution showed that it could well be fitted by two-dimensional Gaussians:

where aA characterizes the distribution width. It is well known that such an initial distribution develops by diffusion according to

Here *D* is the diffusion constant and *N*~A~ is the number of activated fluorophores. Analysis of the results showed that an immobile fraction of *N*~A~ has to be taken into account. We write *N*~A~ as a sum of mobile (*N*~Am~) and immobile (*N*~Ai~) species and introduce the coefficient q = *N*~Ai~/*N*~Am~. Hence, one finds for the decay of the intensity at the activation spot

This expression is the two-dimensional equivalent of Eq. 1 in [@B59], without, however, the terms due to images (at *x~T~* and *x~B~*) and without the bleaching factor exp(−λ*t*). The constant term

has been lumped together as offset *o* in [@B59]. Because σ~A~ can be found from the first frame (after activation), *D* can be deduced by fits to the experimentally observed decays using *D* and *q* as fit parameters. Typically, *q* is of the order of several 10%.

Subcellular fractionations
--------------------------

Separation in a total membrane and a cytosol fraction was performed essentially as described previously ([@B58]). PC12 cells that had been lentivirally infected with the respective construct were cultured on a 10-cm cell culture dish until confluency, washed with PBS, and homogenized on ice in 0.5 ml of hypotonic buffer (10 mM Tris, 10 mM KCl, 1 mM ethylene glycol tetraacetic acid \[EGTA\], and 0.5 mM MgCl~2~, pH 7.4, containing 1 mM phenylmethylsulfonyl fluoride \[PMSF\], 10 μg/ml leupeptin, 10 μg/ml pepstatin, 1 mM sodium orthovanadate, 20 mM NaF, and 1 mM sodium pyrophosphate) using a Dounce stainless steel homogenizer (Wheaton, Millville, NJ). The homogenate was centrifuged for 5 min at 2000 × *g* to obtain a postnuclear supernatant, which was then centrifuged for 20 min at 110,000 × *g*. The supernatant (cytosolic) fraction was saved and the pellet (membrane) fraction resuspended in 50 μl of hypotonic buffer. Same volumes of cytosolic and membrane fraction were separated by SDS--PAGE and analyzed by immunoblot.

Microsphere separation of the plasma membrane was performed from PC12 cells based on a method that has been described previously ([@B34]). Cells that had been transiently transfected with the respective construct were cultured on a 10-cm cell culture dish, surface labeled with sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate (Pierce, Thermo Scientific, Rockford, IL), and incubated with streptavidin-coated microspheres. Cellular homogenates were prepared by freeze-thawing the scraped-off cells in a separation buffer (0.25 M sucrose containing 1 mM ATP, 1 mM MgCl~2~, 1 mM EGTA, 1 mM PMSF, 10 μg/ml leupeptin, 10 μg/ml pepstatin, 1 mM sodium orthovanadate, 20 mM NaF, and 1 mM sodium pyrophosphate), and the plasma membrane/membrane cortex fraction was separated with a magnetic bead attractor. The unbound material was separated by ultracentrifugation into an organelle/membrane pellet and a cytosol fraction. The organelle/membrane pellet was homogenized (five strokes) in 100 mM sodium carbonate buffer, pH 11.5, to remove peripherally bound proteins ([@B60]). After incubation for 30 min on ice, the membrane pellet was collected by centrifugation for 1 h at 190,000 × *g* and washed in PBS. The final pellet was resuspended in a small volume of 0.25 M sucrose--containing protease inhibitors. Cytosolic fractions were precipitated with trichloroacetic acid/Na-deoxycholate ([@B7]).

Palmitoylation analysis of GAP43
--------------------------------

PC12 cells that were transduced with lentivirus expressing different GAP43-PAGFP variants were incubated with 400 μCi/ml \[^3^H\]palmitate in 600 μl of medium for 2 h or 160 μCi/sample (PerkinElmer, Waltham, MA) for 4 h. Cells were then washed three times with the medium to remove unincorporated palmitate. Cells were scraped and lysed with RIPA buffer for 15 min on ice and centrifuged at 16,000 rpm for 30 min to remove cell debris. Cleared-up lysates were subjected to immunoprecipitation with GFP traps (ChromoTek, Martinsried, Germany) for 4 h at 4°C. GFP traps were washed four times with RIPA buffer. Amount of incorporated palmitate into GAP43 variants was measured using a Berthold scintillation counter. Results were similar for both incubation conditions and combined for presentation and statistical analysis.

Modeling
--------

### Problem formulation.

We outlined first the general equations underlying fluorescence recovery at a cellular tip. In a three-dimensional space with the cylindrical coordinate system, we introduced two cylindrical surfaces with the radii R and R0, relating as R \> R0 and R/R0 ≈ 1 (see [Figure 8B](#F8){ref-type="fig"}). We assumed a cellular process to be a two-part half-infinite cylinder bounded by the bigger surface from the outer side and separated into two parts by the smaller one. We considered molecules that diffuse with diffusion constant *D* inside the cylinder and bind to immobile binding sites within the outer part of the cylinder ("reaction layer," R0 \< r ≤ R) with association and dissociation rates *k*~on~ and *k*~off~, respectively. In the inner part of the cylinder ("cytosol,"r ≤ R0), the molecules do not undergo any reactions but are partly transported toward the cellular tip at a fraction m \< 1 and with an average velocity v. Here C(r→,t) and S(r→,t) are the concentrations of free and bound molecules, respectively. If the nonactivated system is at equilibrium and the number of binding sites for the molecules is not affected by photoactivation, the resulting transport-reaction-diffusion system appears as follows:

where , B~eq~ is the equilibrium concentration of free binding sites, and D is the 3D Laplacian operator. Boundary conditions were chosen in such a way that there is no flux of proteins through the outer membrane, as well as through the closed end of the process. Another important requirement was the matching condition on the surface separating the "reaction" and "cytosolic" layers. This demanded that the concentration of free molecules be continuous everywhere on the surface r = R0 together with its first derivative. The last requirement consisted in the finiteness of the solution at the point r = 0. Finally, the boundary and matching conditions were mathematically expressed as

Because the fluorescence recovery at the tip of the process had to be analyzed, it was necessary to define the tip and the corresponding activation region. In our case we introduced a cross section {x = L}, which was supposed to serve as a boundary between the tip and the activation region (AR).

Initial conditions represented the distribution of activated proteins over the process at the initial time point, t = 0. At this time point, it was assumed that all the activated proteins are kept out of the tip. Hence, the initial conditions are given by

where *C*~eq~ is the equilibrium concentration of the activated proteins within the process, *S*~eq~ is the equilibrium concentration of the bound proteins within the reaction layer, and *C*~tot~ is the total concentration of the activated proteins. The last step in the problem formulation was to define the fluorescence recovery at the tip. To do this, we used the fact that the intensity observed in the LSM system was proportional to the concentration of visible proteins averaged over the cellular tip. This resulted in the following expression for unitless normalized intensity:

where the angle brackets denote the spatial averaging over the tip and normalization of the intensity to the 0--1 range.

### Simplified systems.

The full model (Eqs. 2 and 3) described possible behavior of a protein diffusing in a strongly heterogeneous medium where the protein, depending on the location in the process, was either partly transported or underwent a reversible single-binding reaction with an immobile substrate. However, simplified scenarios could be considered. The first simplification arises if we assume all the proteins to be neither transported nor reacting. Under these circumstances, we can set the fraction of transported proteins in Eq. 2, m, equal to zero. Binding in Eq. 3 can be ignored in the same way, and the system of Eqs. 2 and 3 reduces to the diffusion equation

Thus, in the case when both the binding and transport are negligible, the fluorescence recovery at the tip can be determined only by two parameters, namely, the diffusion constant D and the tip length L. The second simplification arises when only the fraction of transported proteins m is negligible but the reaction plays a considerable role in trapping the proteins within the reaction layer. Hence, the system of Eqs. 2 and 3 changes to

The choice of the foregoing simplified cases was not accidental but was believed to describe the behavior of two control constructs: 3×PAGFP and PAGFP-F. Whereas 3×PAGFP displayed fully cytosolic distribution and acted most likely as a freely diffusing protein, PAGFP-F was mostly located at the membrane, suggesting a strong interaction with it. Thus the simplified cases could characterize the dynamics of the control constructs.

Analysis of the transport-reaction-diffusion equations
------------------------------------------------------

The transport-reaction-diffusion equations were analyzed in order to obtain analytical solutions for *I*(*t*). The solutions for the simplified cases have been found in closed form using the Laplace transform method, , taken from the whole system of equations. The analytical solution for the full system could be found only up to the point where the inverse Laplace transform had to be calculated. The numerical algorithm ([@B54]) was therefore used to compute the inverse Laplace transform. Because the fluorescence recovery at the tip was the sum of free and bound fluorescence averaged over the tip, we first had to compute the Laplace transform for this sum:

where p is the Laplace variable (the inverse time). Then we performed the averaging over the tip region by calculating the following integral:

The final expression for *I*(*t*) was obtained either via the inverse Laplace integral or by applying the aforementioned numerical algorithm.

Other methods
-------------

SDS--PAGE and immunoblot analysis were performed as described previously ([@B28]). Statistical evaluation was performed using two-tailed, unpaired Student\'s *t* test to compare two means and one-sample Student\'s *t* test to compare the mean with a hypothetical value. Data are shown as mean ±SEM. *p* values for all analysis are set as follows: \*^(o)^*p* \< 0.05, \*\**p* \< 0.01, and \*\*\**p* \< 0.001.

This article was published online ahead of print in MBoC in Press ([http://www .molbiolcell.org/cgi/doi/10.1091/mbc.E13-12-0737](http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E13-12-0737)) on August 27, 2014.
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AD

:   Alzheimer\'s disease

FDAP

:   fluorescence decay after photoactivation

GAP43

:   growth-associated protein 43

PAGFP

:   photoactivatable green fluorescent protein

PKC

:   protein kinase C

TIRF

:   total internal reflection fluorescence
